Dexcom Stelo vs. Abbott Lingo: 5 Things to Know About the New Over-the-Counter CGM Market
The world of continuous glucose monitoring (CGM) is getting more exciting, with new players entering the market and making these life-changing devices more accessible. Dexcom’s Stelo and Abbott’s lingo are two of the latest additions, both offering over-the-counter (OTC) options for individuals looking to track their blood sugar levels without a prescription.
But which one is right for you? Here are five key insights to help you navigate this new landscape:
1. Direct-to-Consumer Distribution: Both Stelo and Lingo are taking a direct-to-consumer approach, bypassing traditional healthcare providers. Dexcom plans to sell Stelo exclusively through its website, while Abbott aims to make Lingo available directly to consumers as well. This shift promises greater convenience and perhaps lower costs for users. [[2]]
2. Price Point: Stelo is priced at $22.50 per week, making it a more affordable option compared to some prescription CGMs. [[1]] While Abbott hasn’t publicly released Lingo’s pricing, it’s expected to be competitive within the OTC market.
3. Data Integration: Stelo stands out with its seamless integration with Apple Health, allowing users to export glucose data directly into the platform. This feature is currently unavailable with Abbott’s other CGM offerings.[[1]]
4. Sensor Design: Early user feedback suggests that Stelo’s sensor patch can become less aesthetically pleasing over time. [[1]] Abbott’s Lingo, on the other hand, has received praise for its comfortable and discreet sensor design.[[3]]
5. Accuracy and Features: Both Stelo and Lingo are designed to provide accurate glucose readings and offer features like trend arrows and alerts. However, Dexcom’s Stelo boasts a faster update rate of every 5 minutes compared to Lingo’s less frequent readings. [[1]]
The arrival of Stelo and Lingo marks a significant step forward in making CGM technology more accessible and affordable. As the market continues to evolve, we can expect even more innovative and user-friendly options to emerge, empowering individuals to take control of their health.
Dexcom Stelo vs. Abbott Lingo: A Guide to the new OTC CGM Market
Time.news Editor: Welcome, Dr. Lee, to Time.news. Today we’re diving into the exciting world of continuous glucose monitoring (CGM) with the launch of two new over-the-counter (OTC) options: Dexcom Stelo and Abbott Lingo. For our readers unfamiliar with CGM, can you briefly explain what it is and why it’s becoming increasingly important?
Dr.Lee: Certainly. Continuous glucose monitoring (CGM) is a game-changer for people managing diabetes. It provides real-time glucose readings, not just thru finger pricks like traditional methods, but continuously throughout the day and night. This constant data flow empowers individuals to understand how their blood sugar fluctuates in response to food, exercise, stress, and other factors.
Time.news Editor: That’s incredibly valuable facts. Now,Dexcom Stelo and Abbott Lingo both offer this technology OTC. How does this direct-to-consumer approach impact the accessibility and affordability of CGM?
Dr. Lee: it’s a meaningful development. Previously, CGMs often required a prescription from a healthcare provider, which involved appointments and perhaps higher costs. Stelo and Lingo bypassing this traditional route makes CGM more accessible to a wider population, potentially reducing barriers to care and promoting better blood sugar management.
time.news Editor: Speaking of accessibility, what are the key differences between Stelo and Lingo that individuals should consider when making their decision?
Dr. Lee: The pricing is a good starting point. Stelo is currently more affordable at $22.50 per week, while Abbott hasn’t publicly announced Lingo’s pricing but plans for competitive positioning. Integration with existing health platforms is another differentiator. Stelo seamlessly connects with Apple Health, which is a huge advantage for Apple users, allowing them to conveniently track their glucose data alongside other health metrics. Lingo, on the other hand, might cater more to Android users or those who prefer a standalone platform.
Time.news Editor: User experience is crucial. What feedback have we seen regarding the sensor design and overall comfort of these devices?
Dr.Lee: Early reports suggest Stelo’s sensor patch might become less visually appealing over time, while Lingo is consistently praised for its discreet and pleasant sensor design. Comfort and aesthetics are highly personal preferences, so it’s essential to consider individual needs.
Time.news Editor: Lastly, accuracy and features are paramount in a CGM. How do Stelo and Lingo perform in these areas?
dr. Lee: Both devices are designed for accurate glucose readings but differ in update rates.stelo offers a faster update rate of every 5 minutes, providing more frequent data points. Lingo, while still reliable, has a less frequent update. Both offer valuable features like trend arrows and alerts, which help users anticipate and manage blood sugar fluctuations.
time.news Editor: Thank you, Dr. Lee, for your insightful explanations. This information will undoubtedly be helpful for our readers navigating the exciting new world of affordable and accessible CGM.
